Heart disease and stroke Statistics-2019 update a report from the.

American Heart Association. ()

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Circulation: Heart Failure. 6: 606-619

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study.

The Lancet, 2017. 390: 1260-1344

Administration, S.A.a.M.H.S., RESULTS FROM THE 2017 NATIONAL SURVEY ON DRUG USE AND HEALTH: DETAILED TABLES. 2017: https://www.samhsa.gov/.

The impact of substance abuse on heart failure hospitalizations.

The American Journal of Medicine. 133 (): 207-213

National rate of tobacco and substance use disorders among hospitalized heart failure patients.

The American journal of medicine. 132 (): 478-488

Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Journal of the American Heart Association. 9e016704

Cardiac effects of opioid therapy.

Pain Medicine. 16: S27-S31

Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?.

British journal of pharmacology. 154: 288-298

Alcohol's Effects on the Cardiovascular System.

Alcohol research : current reviews. 38: 219-241Wannamethee G. Shaper A.G.

Alcohol and sudden cardiac death.

Br Heart J. 68: 443-448

Increased stroke risk is related to a binge-drinking habit.

Stroke. 39: 3179-3184

Binge drinking and mortality after acute myocardial infarction.

Circulation. 112: 3839-3845

Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case–control study.

Circulation. 130: 390-398

Alcohol consumption and risk of incident heart failure in older men: a prospective cohort study.

Open Heart. 2

Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease.

The American journal of cardiology. 96: 346-351

Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology.

Chest. 121: 1638-1650

Alcoholic heart disease: a review.

Heart & lung: the journal of critical care. 23: 3

Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy.

European heart journal. 21: 306-314

Alcohol abuse and heart failure.

European journal of heart failure. 11: 453-462

Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study.

American heart journal. 135: 833-837

Alcoholic cardiomyopathy: pathophysiologic insights.

Cardiovascular toxicology. 14: 291-308

Mechanisms of alcoholic heart disease.

Therapeutic advances in cardiovascular disease. 2: 497-506

Etiology of alcoholic cardiomyopathy: mitochondria, oxidative stress and apoptosis.

The international journal of biochemistry & cell biology. 89: 125-135

Ethanol and acetaldehyde in alcoholic cardiomyopathy: from bad to ugly en route to oxidative stress.

Alcohol. 32: 175-186

Cobalt cardiomyopathy: a critical reappraisal in light of a recent resurgence.

Circulation: Heart Failure. 9e003604Fernández-Solà J. et al.

Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy.

Annals of internal medicine. 137 (): 321-326

Natural history and prognostic factors in alcoholic cardiomyopathy.

JACC: Heart Failure. 3: 78-86

The effect of controlled drinking in alcoholic cardiomyopathy.

Annals of internal medicine. 136: 192-200Albert M.A. Glynn R.J. Ridker P.M.

Alcohol consumption and plasma concentration of C-reactive protein.

Circulation. 107: 443-447

Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance.

The Journal of Clinical Endocrinology & Metabolism. 90: 661-672

Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.

Circulation. 104: 1367-1373

Alcohol consumption and lipoprotein subclasses in older adults.

The Journal of Clinical Endocrinology & Metabolism. 92: 2559-2566

The good, the bad, and the ugly with alcohol use and abuse on the heart.

Alcoholism: Clinical and Experimental Research. 37: 1253-1260

Moderate alcohol consumption and risk of heart failure among older persons.

Jama. 285: 1971-1977

The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study.

J Am Coll Cardiol. 48: 305-311

Alcohol consumption and risk of heart failure in the Physicians' Health Study I.

Circulation. 115: 34-39

Alcohol consumption and heart failure: a systematic review.

Curr Atheroscler Rep. 10: 117-120Larsson S.C. Orsini N. Wolk A.

Alcohol consumption and risk of heart failure: a dose-response meta-analysis of prospective studies.

Eur J Heart Fail. 17: 367-373

Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study.

Ann Intern Med. 136: 181-191Cooper H.A. Exner D.V. Domanski M.J.

Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction.

J Am Coll Cardiol. 35: 1753-1759

Low-to-moderate alcohol intake and health status in heart failure patients.

J Card Fail. 11: 323-328

Moderate alcohol consumption predicts long-term mortality in elderly subjects with chronic heart failure.

J Nutr Health Aging. 17: 480-485

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Circulation. 107: 2920-2925

Csengeri, D., et al., Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes. European Heart Journal, 2021.

Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study.

Am J Public Health. 106: 1586-1591

Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Am J Gastroenterol. 114: 1574-1586Benowitz N.L. Burbank A.D.

Cardiovascular toxicity of nicotine: implications for electronic cigarette use.

Trends in cardiovascular medicine. 26: 515-523

Service, U.S.P.H., et al., How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. 2010: US Government Printing Office.

Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone.

Circulation. 73: 662-667

Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels.

Journal of the American College of Cardiology. 22: 642-647

Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease.

Journal of the American College of Cardiology. 4: 964-971

Cigarette smoking induces atrial fibrosis in humans via nicotine.

Heart. 93: 1056-1063

Current cigarette smoking among adults—United States, 2005–2015.

Morbidity and Mortality Weekly Report. 65: 1205-1211

Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study.

American heart journal. 164: 236-242

Risk of heart failure and death after prolonged smoking cessation: role of amount and duration of prior smoking.

Circulation: Heart Failure. 8: 694-701

Cigarette smoking and incident heart failure: insights from the Jackson Heart Study.

Circulation. 137: 2572-2582

Relation between cigarette smoking and heart failure (from the Multiethnic Study of Atherosclerosis).

The American journal of cardiology. 123: 1972-1977

Impact on cardiovascular outcomes among e-cigarette users: a review from national health interview surveys.

Journal of the American College of Cardiology. 73: 11

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Archives of internal medicine. 161: 996-1002

Cardiovascular effects of long-term cigarette smoking and nicotine administration.

The American journal of cardiology. 37: 33-40

Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging.

Journal of the American Society of Echocardiography. 15: 1232-1237

Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies.

European Journal of Preventive Cardiology. 26: 279-288

Son, Y.-J. and H.-J. Lee, Association between persistent smoking after a diagnosis of heart failure and adverse health outcomes: A systematic review and meta-analysis. Tobacco Induced Diseases, 2020. 18.

Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.

American Heart Journal. 230: 25-34

Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials.

Circulation: Cardiovascular Quality and Outcomes. 10e002458

Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.

Journal of the American Heart Association. 5e002849

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Circulation. 129: 28-41

Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.

Journal of the American College of Cardiology. 22: 1159-1167

Cannabis, a complex plant: different compounds and different effects on individuals.

Ther Adv Psychopharmacol. 2: 241-254

Cardiovascular complications of marijuana and related substances: a review.

Cardiology and therapy. 7: 45-59

Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week.

J Am Coll Cardiol. 75: 320-332

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Trends Pharmacol Sci. 30: 515-527

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Nat Rev Cardiol. 15: 151-166

The Protective Mechanism of Cannabidiol in Cardiac Injury: A Systematic Review of Non-Clinical Studies.

Curr Pharm Des. 25: 2499-2507Garza-Cervantes J.A. et al.

Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure.

Oxid Med Cell Longev. 20204587024Beaconsfield P. Ginsburg J. Rainsbury R.

Marihuana smoking: cardiovascular effects in man and possible mechanisms.

New England Journal of Medicine. 287: 209-212Kanakis Jr, C. Pouget J.M. Rosen K.M.

The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.

Circulation. 53: 703-707

Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men.

Annals of Internal Medicine. 89: 448-452

Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms.

Clinical Pharmacology & Therapeutics. 25: 440-446

Cannabis and coronary thrombosis: what is the role of platelets?.

Platelets. 23: 243-245

Δ 9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles.

Journal of Inflammation. 12: 1-6

Myocardial infarction following cannabis induced coronary vasospasm.

BMJ Case Rep, 2014.

Is recent cannabis use associated with acute coronary syndromes? An illustrative case series.

Acta Cardiol. 69: 131-136

Marijuana use and long-term mortality among survivors of acute myocardial infarction.

American Heart Journal. 165: 170-175

Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.

Journal of the American College of Cardiology. 71: 2540-2551

Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample.

Journal of Cardiovascular Medicine. 19: 480-484

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats.

Nature protocols. 3: 1422

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

J Cardiovasc Pharmacol. 41: 657-664

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.

J Am Coll Cardiol. 50: 528-536Nogi M. Fergusson D. Chiaco J.M.C.

Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report.

Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health. 73: 115-118

Marijuana (cannabis) use is an independent predictor of stress cardiomyopathy in younger men.

Circulation. 134: A14100

Marijuana induced myocarditis: a new entity of toxic myocarditis.

American journal of medical case reports. 6: 169

Marijuana Smoking is Associated With Atrial Fibrillation.

The American Journal of Cardiology. 113: 1085-1086

Burden of arrhythmia in recreational marijuana users.

International Journal of Cardiology. 264: 91-92

Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report.

Cases journal. 1: 373

Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association.

Circulation. 142: e131-e152

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

Proc Natl Acad Sci U S A,. 95: 8268-8273

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Neuropharmacology. 54: 244-249

In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats.

Frontiers in Pharmacology. 8: 248

Durst, R., et al., Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology, 2007.

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

Journal of the American College of Cardiology. 56: 2115-2125

Cannabidiol limits T cell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.

Molecular Medicine. 22: 136-146

Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

Pharmacology. 21: 175-185

Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome.

New England Journal of Medicine. 376: 2011-2020Jadoon K.A. Tan G.D. O'Sullivan S.E.

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.

JCI insight. 2Egashira K. Morgan K.G. Morgan J.P.

Effects of cocaine on excitation-contraction coupling of aortic smooth muscle from the ferret.

The Journal of clinical investigation. 87: 1322-1328Jones S.R. Garris P.A. Wightman R.M.

Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens.

Journal of Pharmacology and Experimental Therapeutics. 274: 396-403

Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool.

Journal of Neuroscience. 26: 3206-3209

Hemodynamic effects of intranasal cocaine in humans.

Journal of the American College of Cardiology. 20: 90-93

Cocaine-induced coronary-artery vasoconstriction.

New England Journal of Medicine. 321: 1557-1562

Role of nitric oxide in cocaine-induced acute hypertension.

American journal of hypertension. 11: 708-714

Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with σ-receptor antagonists.

Circulation. 98: 385-390

Effects of cocaine on nitric oxide production in bovine coronary artery endothelial cells.

Journal of Pharmacology and Experimental Therapeutics. 314: 980-986

Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

British journal of clinical pharmacology. 69: 427-442

Effects of cocaine and its major metabolites on the HERG-encoded potassium channel.

Journal of Pharmacology and Experimental Therapeutics. 299: 220-226

Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).

The American journal of cardiology. 102: 1216-1219Havakuk O. Rezkalla S.H. Kloner R.A.

The cardiovascular effects of cocaine.

Journal of the American College of Cardiology. 70: 101-113

Cocaine-induced myocardial infarction in patients with normal coronary arteries.

Annals of Internal Medicine. 115: 797-806

Effects of cocaine on human platelets in healthy subjects.

The American journal of cardiology. 72: 243-246

Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis.

Journal of the American College of Cardiology. 17: 1553-1560

Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey.

Circulation. 103: 502-506

Prospective multicenter evaluation of cocaine-associated chest pain.

Academic Emergency Medicine. 1: 330-339Wiener R.S. Lockhart J.T. Schwartz R.G.

Report of two cases.

The American journal of medicine. 81: 699-701Awtry E.H. Philippides G.J.

Alcoholic and cocaine-associated cardiomyopathies.

Progress in cardiovascular diseases. 52: 289-299

Cocaine and the heart.

Human pathology. 18: 195-199

Cardiovascular effects of cocaine: an autopsy study of 40 patients.

American heart journal. 115: 1068-1076

Acute cardiac events temporally related to cocaine abuse.

New England Journal of Medicine. 315: 1438-1443Perreault C.L. Morgan K.G. Morgan J.P.

Effects of cocaine on intracellular calcium handling in cardiac and vascular smooth muscle.

NIDA Res Monogr. 108: 139-153

Effects of the intracoronary infusion of cocaine on left ventricular systolic and diastolic function in humans.

Circulation. 97: 1270-1273

The effects of cocaine on intracellular Ca2+ handling and myofilament Ca2+ responsiveness of ferret ventricular myocardium.

British journal of pharmacology. 101: 679-685

Frequency of coronary artery disease and left ventricular dysfunction in cocaine users.

The American journal of cardiology. 69: 1549-1552

Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population.

Clinical cardiology. 13: 323-328

Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T.

Journal of Cardiovascular Magnetic Resonance. 16: 1-12

Cardiac magnetic resonance in cocaine-induced myocardial damage: cocaine, heart, and magnetic resonance.

Heart Failure Reviews. : 1-8

Cocaine, cardiomyopathy, and heart failure: a systematic review and meta-analysis.

Scientific reports. 10: 1-8

Comparison of frequency of cardiovascular events and mortality in patients with heart failure using versus not using cocaine.

The American journal of cardiology. 119: 2030-2034Willens H.J. Chakko S.C. Kessler K.M.

Cardiovascular manifestations of cocaine abuse: a case of recurrent dilated cardiomyopathy.

Chest. 106: 594-600

Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on.

Clinical Cardiology. Circulation. 117: 1897-1907Ramoska E. Sacchetti A.D.

Propranolol-induced hypertension in treatment of cocaine intoxication.

Annals of emergency medicine. 14: 1112-1113

Mann, B.K., et al., Beta Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review. Cardiology Research and Practice, 2020. 2020.

Heart failure and adverse drug reactions among hospitalized older adults.

Clinical Pharmacology & Therapeutics. 86: 307-310

Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure.

International journal of clinical pharmacology. 22 (): 595

Medicinal cannabis—potential drug interactions.

Medicines. 6: 3

Drug interactions with tobacco smoking.

Clinical pharmacokinetics. 36: 425-438Clinics in liver disease. 16 (): 667-685